Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 4/20 | 0.46 |
| ▸ | CA1 | P00915 | 4/20 | 0.46 |
| ▸ | CA9 | Q16790 | 4/20 | 0.46 |
| ▸ | PREP | P48147 | 4/20 | 0.38 |
| ▸ | APLNR | P35414 | 2/20 | 0.33 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.31 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5509632 | 0.80 | CA12 (0.43) | CA12CA1CA9PREPHSP90AA1 | |
| SCHEMBL25370505 | 0.78 | CA12 (0.41) | CA12CA1CA9PREP | |
| SCHEMBL5736709 | 0.76 | CA12 (0.44) | CA12CA1CA9PREPAPLNR | |
| SCHEMBL6763899 | 0.76 | PREP (0.53) | CA12CA1CA9PREPHSP90AA1 | |
| SCHEMBL4651487 | 0.75 | CA12 (0.43) | CA12CA1CA9PREPAPLNR | |
| SCHEMBL24456188 | 0.75 | CA12 (0.43) | CA12CA1CA9PREPAPLNR | |
| SCHEMBL3805134 | 0.74 | CA12 (0.40) | CA12CA1CA9PREP | |
| SCHEMBL596046 | 0.73 | CA12 (0.42) | CA12CA1CA9PREPAPLNR | |
| SCHEMBL17672515 | 0.73 | CA12 (0.42) | CA12CA1CA9PREPAPLNR | |
| SCHEMBL7706827 | 0.72 | CA1 (0.50) | CA12CA1CA9PREPHSP90AA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7935836-B2 | Compounds comprising a linear series of five fused carbon rings, and preparation thereof | FALLIS ALEXANDER GRAHAM | 2011-05-03 | — | — | US | disclosed |
| US-20100004467-A1 | COMPOUNDS COMPRISING A LINEAR SERIES OF FIVE FUSED CARBON RINGS, AND PREPARATION THEREOF | FALLIS ALEXANDER GRAHAM | 2010-01-07 | — | — | US | disclosed |
| US-20060267004-A1 | Compounds comprising a linear series of five fused carbon rings, and preparation thereof | UNIVERSITY OF OTTAWA (CA) | 2006-11-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100004467-A1 | COMPOUNDS COMPRISING A LINEAR SERIES OF FIVE FUSED CARBON RINGS, AND PREPARATION THEREOF | JUP, CDH1, EML4 | CA12 926/4885CA1 1324/4885CA9 1102/4885 |
| US-20060267004-A1 | Compounds comprising a linear series of five fused carbon rings, and preparation thereof | JUP, LATS2, CDH1 | CA12 1813/4885CA1 1374/4885CA9 1028/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.